The global Stoma Care market gathered revenue around USD 460 Million in 2020 and market is set to grow USD 810 Million by the end of 2027 and is estimated to expand at a modest CAGR of 7.1% during the prediction period 2021 to 2027.
Growth Factors:
The market Increasing cases of colorectal cancer and bladder cancer, Inflammatory Bowel Disease (IBD), adoption of advanced technologies and rising awareness regarding stoma care products are the key driving factors for the market. In addition, the increasing prevalence in the young population is expected to upsurge the demand for stoma care and accessories during the forecast period. The COVID-19 pandemic had a detrimental effect on the market.
Increasing cases of colorectal cancer, inflammatory bowel disease (IBD), increasing adoption of advanced technologies, and rising awareness regarding stoma care products are the key driving factors for the market.
Colorectal cancer is the most common cause of stomas, accounting for about 46.1% of all cases. More than 45.0% of colostomies are performed in ostomy patients aged 60 above, thereby surging the demand for healthcare products. In addition, colorectal cancer is the third most common form of cancer in both men and women. For instance, according to the report published by the World Health Organization (WHO), in 2020,9,35,000 deaths were reported out of 1.97 million cases due to colorectal cancer. Although it is more prevalent in adults aged 50 and older, however, the incidence rate has increased by 2.3% annually in individuals younger than 50 years.
For instance, according to the American Cancer Society, about 1.4 lakh individuals were diagnosed with colorectal cancer in 2020 of which 12.00% were individuals younger than 50. Furthermore, according to the National Center for Biotechnology Information (NCBI), colorectal cancer is the deadliest among males in UAE and deadliest among females in Japan. Therefore, such instances indicate a considerable increase in demand for healthcare products, as it is one of the essential requirements for treating such cases, thereby propelling market growth over the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Stoma Care market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Stoma Care market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 810 Million by 2027 |
Growth Rate | CAGR of 7.1% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Product, application, end-use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Coloplast; B. Braun Melsungen AG; Hollister Incorporated; ConvaTec Inc.; Salts Healthcare; Welland Medical Limited. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Stoma Care market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
Europe dominated the stoma care market and accounted for the largest revenue share of 48.1% in 2020. The region is expected to witness considerable growth over the forecast period. Factors such as an increase in the number of stoma patients due to Crohn’s disease and ulcerative colitis or IBD are expected to drive the growth of the market in Europe during the forecast period. In Europe, about 731,000 people live with an ostomy. According to NCBI, IBD comprises Crohn’s disease or ulcerative colitis, and its occurrence in European countries is steadily rising. According to the Journal of Crohn’s and Colitis, the incidence of ulcerative colitis and Crohn’s disease in Europe is increasing every year. It has been estimated that 0.9% of the total population in Europe suffers from IBD. The highest incidence was witnessed in the U.K., while the lowest was seen in eastern and southern Europe. Thus, the increasing incidence of IBD is primarily driving market growth in Europe.
In Asia Pacific, the market is anticipated to exhibit lucrative growth during the forecast period. Several nursing centers in this region arrange a range of programs, including motivational programs and educational seminars, to increase awareness among ostomy patients. According to Asia and South Pacific Ostomy Association (ASPOA), world ostomy day is organized every year to improve the rehabilitation of ostomates by bringing their aspirations and needs to the attention of the general public and the global community. Activities to promote awareness worldwide include seminars, educational programs, support meetings and demonstrations, electronic information networks, magazine announcements, articles and advertisements, and video and audio announcements. Thus, increasing awareness among consumers is boosting the market growth in this region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Stoma Care Market include: Coloplast; B. Braun Melsungen AG; Hollister Incorporated; ConvaTec Inc.; Salts Healthcare; Welland Medical Limited.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Stoma Care market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Stoma Care market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Stoma Care markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Stoma Care market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Closed Bags Market, By Product
7.1. Closed Bags Market, By Product, 2021-2027
7.1.1. Closed Bags
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Open/ drainable Bags
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. One-piece Bags
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Two-piece Bags
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Closed Bags Market, By Application
8.1. Closed Bags Market, by Application, 2021-2027
8.1.1. Colostomy
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Ileostomy
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Urostomy
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Closed Bags Market, By End User
9.1. Closed Bags Market, by End User, 2021-2027
9.1.1. Homecare Settings
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Homecare Settings
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Closed Bags Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2027)
Chapter 11. Company Profiles
11.1. Coloplast
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. B. Braun Melsungen AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hollister Incorporated
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ConvaTec Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Salts Healthcare
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Welland Medical Limited.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms